Just one other small thing I noticed:
The current Her-vaxx Phase 2 trial has acquired a groovy new name - "HERIZON" - as featured in the recent ASCO and ESMO conference presentations and the related article in the Journal of Clinical Oncology - https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e16065
Along with the recent appointment of Monil Shah as Chief Business Officer, I see this as a sign that Imugene is sharpening its marketing....
Cheers
Dave
Media Thread, page-2207
-
- There are more pages in this discussion • 13,636 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.9¢ | $900.1K | 18.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 15456501 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 1713619 | 8 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |